Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis by Karabis A, Lindner L, Mocarski M, Huisman E, Greening A

Get full text

The current single exhalation method of measuring exhales nitric oxide is affected by airway calibre. by Ho, L, Wood, F, Robson, A, Innes, J, Greening, A

Reduced interleukin-18 levels in BAL specimens from patients with asthma compared to patients with sarcoidosis and healthy control subjects. by Ho, L, Davis, M, Denison, A, Wood, F, Greening, A

Current single exhalation method of measuring exhaled nitric oxide is affected by airway calibre. by Ho, L, Wood, F, Robson, A, Innes, J, Greening, A

Atopy influences exhaled nitric oxide levels in adult asthmatics. by Ho, L, Wood, F, Robson, A, Innes, J, Greening, A

IL-18 levels are markedly reduced in broncho-alveolar lavage from asthmatics compared to sarcoids and normal subjects. by Ho, L, Davis, M, Denison, A, Wood, F, Greening, A

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS: THE RUN-IN STUDY by Alton, E, Boyd, C, Cunningham, S, Davies, J, Hyde, S, Ianes, J, Gill, D, Greening, A, Griesenbach, U, Higgins, T, Porteous, D

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS; THE RUN-IN STUDY by Alton, E, Boyd, C, Cunningham, S, Davies, J, Hyde, S, Innes, J, Gill, DR, Greening, A, Griesenbach, U, Higgins, T, Porteous, D, Consortium, UKCFGT

UKCF gene therapy consortium tracking study: Sputum and serum calprotectin are useful novel measurements in CF exacerbation by Gray, R, Horsley, A, Macleod, K, Imrie, M, Dewar, M, Voase, N, Donovan, J, Hyde, S, Gill, D, Griesenbach, U, Davies, J, Alton, E, Boyd, A, Porteous, D, Cunningham, S, Innes, J, Greening, A

A randomized, double-blind, placebo-controlled trial of repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis by Alton, E, Armstrong, D, Bayfield, K, Bilton, D, Boyd, A, Cheng, S, Cunningham, S, Davies, J, Elgmati, H, Gill, D, Greening, A, Griesenbach, U, Harman, K, Higgins, T, Hyde, S, Innes, J, McGovern, M, Murray, G, Porteous, D, Saunders, C, Scheule, R, Simmonds, N, Soussi, S, Sumner-Jones, S, Waller, M

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial by Alton, EWFW, Armstrong, DK, Ashby, D, Bayfield, K, Bilton, D, Bloomfield, E, Boyd, A, Brand, J, Buchan, R, Calcedo, R, Carvelli, P, Chan, M, Cheng, S, Collie, D, Cunningham, S, Davidson, H, Davies, G, Davies, J, Davies, L, Dewar, M, Doherty, A, Donovan, J, Dwyer, N, Elgmati, H, Featherstone, R, Gavino, J, Gea-Sorli, S, Geddes, D, Gibson, J, Gill, D, Greening, A, Griesenbach, U, Hansell, D, Harman, K, Higgins, T, Hodges, S, Hyde, S, Hyndman, L, Innes, J, Jacob, J, Jones, S, Keogh, B, Limberis, M, Lloyd-Evans, P, Maclean, A, Manvell, M, McCormick, D, McGovern, M, McLachlan, G, Meng, C, Montero, M, Milligan, H, Moyce, L, Murray, G, Nicholson, A, Osadolor, T, Parra-Leiton, J, Porteous, D, Pringle, I, Punch, E, Pytel, K, Quittner, A, Rivellini, G, Saunders, C, Scheule, R, Sheard, S, Simmonds, N, Smith, K, Smith, S, Soussi, N, Soussi, S, Spearing, E, Stevenson, B, Sumner-Jones, S, Turkkila, M, Ureta, R, Waller, M, Wasowicz, M, Wilson, J, Wolstenholme-Hogg, P